Report: Combination therapy more effective for diabetics

03/25/2008 | Reuters

A report shows that a combination of simvastatin and fenofibrate works better than either drug alone at normalizing lipid levels in Type 2 diabetes patients who do not have coronary heart disease. "Aggressive treatment of this mixed dyslipidemia may be very important in saving the lives of our diabetic patients," a researcher said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC